Novavax Nuvaxovid(TM) COVID-19 Vaccine Granted Provisional Reg...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., July 27, 2022 /PRNewswire-Asianet/ -- --Nuvaxovid(TM) is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 in AustraliaNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vacci...
Authors: LATEST ASIANET NEWS RELEASES